Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
Invesco Solar ETF
TAN
United States Natural Gas
UNG
4
VanEck Semiconductor ETF
SMH
5
The Technology Select Sector SPDR® Fund
XLK
US Stock MarketDetailed Quotes
Emergent BioSolutions (EBS)
- 8.440
- +0.510+6.43%
Close Jun 4 15:59 ET
- 8.420
- -0.020-0.24%
Post 19:47 ET
435.47MMarket Cap-44.42P/E (TTM)
8.490High8.030Low935.78KVolume8.030Open7.930Prev Close7.79MTurnover1.90%Turnover Ratio9.08P/E (Static)51.60MShares14.06052wk High0.83P/B416.78MFloat Cap5.61552wk Low--Dividend TTM49.38MShs Float137.610Historical High--Div Yield TTM5.80%Range %1.420Historical Low8.323Avg Price1Lot Size
EBS Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
EBS Orderflow
Unit: --
EBS Orderflow Trend
IntradayDayWeekMonth
No Data
Emergent BioSolutions (EBS) News
These 10 Small-cap U.S. Healthcare Giants Rank Among the Market's Most Attractively Valued Stocks
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Emergent Biosolutions (EBS) and Compass Therapeutics (CMPX)
Emergent BioSolutions Wins $64.5M U.S. HHS Contract Modification To Supply Botulism Antitoxin BAT Under Existing 10-Year Agreement
Express News | Emergent BioSolutions Receives $64.5 Million Contract Modification for Bat® [Botulism Antitoxin Heptavalent (a, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
Express News | Bimergen Energy - Jv Company to Issue 75 Class B Units and Pay $1.18 Mln Reimbursement to Emergen - SEC Filing
Emergent BioSolutions to Participate in Upcoming Investor Conferences
Emergent BioSolutions (EBS) Stock Forum
$Emergent BioSolutions (EBS.US)$ Reuters
1m
Emergent BioSolutions Receives $64.5 Million Contract Modification for Bat® [Botulism Antitoxin Heptavalent (a, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
1m
Emergent BioSolutions Receives $64.5 Million Contract Modification for Bat® [Botulism Antitoxin Heptavalent (a, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
1
1
$Emergent BioSolutions (EBS.US)$ Ebola related
$Emergent BioSolutions (EBS.US)$ $SAB Biotherapeutics (SABS.US)$
Reuters
2m
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract With SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142! Executed Agreement Is Valued at Approximately $50 Mln! Under Terms, Co to Provide End-to-End Development, Manufacturing Services to SAB Bio
Reuters
2m
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract With SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142! Executed Agreement Is Valued at Approximately $50 Mln! Under Terms, Co to Provide End-to-End Development, Manufacturing Services to SAB Bio
1
2
$Emergent BioSolutions (EBS.US)$ Emergent BioSolutions Signs ~$34.5M Agreement With Substipharm Biologics Over Drug Substance Production For Its Japanese Encephalitis Vaccine
Benzinga
3m
Emergent BioSolutions Inc. (NYSE:EBS) today announced it has entered into an agreement with Substipharm Biologics valued at approximately $34.5 million to support drug substance manufacturing for its Japanese Encephalitis (JE) vaccine, licensed internationally under the brand name IMOJEV at Emergent's Canton,...
Benzinga
3m
Emergent BioSolutions Inc. (NYSE:EBS) today announced it has entered into an agreement with Substipharm Biologics valued at approximately $34.5 million to support drug substance manufacturing for its Japanese Encephalitis (JE) vaccine, licensed internationally under the brand name IMOJEV at Emergent's Canton,...
$Emergent BioSolutions (EBS.US)$
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
by Globe Newswire
Follow
GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced a series of initiatives designed to help increase access to NARCAN® Nasal Spray and encourage the public to be ready to respond to an opioid overdose. These include the l...
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
by Globe Newswire
Follow
GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced a series of initiatives designed to help increase access to NARCAN® Nasal Spray and encourage the public to be ready to respond to an opioid overdose. These include the l...
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
Trytosaveabit OP : BTW thats on top of the original 123 million dollar contract! Brings total of contract Value now 187 million! Not bad right. A 50%+ increase in contract value!![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")